Loading
Latest filing published 16 Sept 2018 for RISE Life Science Corp..
No signal scores available.
Anton Raynor Mattadeen appears in our data through filings on RISE Life Science Corp. shares, published by SEDI. We count 3 filings, every one of them for a trade on 12 September 2018.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 16 September 2018, the filings show a transaction in RISE Life Science Corp. Typically, a trade is published a median of 4 days after it takes place. Until a filing is published, the market cannot know about the trade. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations